Claya review
Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
- Scores never bought
- 497 providers tracked
- Every factor auditable
- Updated July 2026
Claya earns a Match Score of 65/100 (grade C) and sits #194 of 497 on our board under the balanced default weighting.
- Semaglutide
- $299/mo (compounded)
- Tirzepatide
- $299/mo (compounded)
- Coverage
- Coverage not published
- Brand-name
- Compounded only
- Oral option
- Yes
- Verification
- Not independently listed
Best for: People who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
MatchScript's take: Our #194 pick of 497 — one of the few with a non-injection route, scored on the same six factors as everyone else.
The factor breakdown
Claya on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $299/mo (compounded) puts Budget Fit at a below-par 43 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a below-par 60 on Speed to Start.
Claya adds an oral/sublingual route on top of injectables, for a middling 77 on Formulary Match.
Support lands at a middling 78 — lighter, meds-first support.
Flexibility scores a below-par 61 — fewer levers to flex your plan.
Disclosure here is thinner than the top of the board give a below-par 72 on Transparency.
Pricing in context
How Claya's monthly price sits against the category median and the cheapest provider we track.
What we like
- Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- Weight-loss money-back guarantee published on the homepage
- Free expedited shipping included in the monthly price
The caveats
- States-served list not disclosed — you must check at checkout
- LegitScript certification status not displayed
- Corporate legal entity not disclosed on the site or privacy policy
- Oral compounded tablets have weaker efficacy data than injectable semaglutide
- Intro pricing is higher at refill ($299), erasing the first-month advantage
Who it's for — and who should skip it
Choose Claya if people who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
Skip it if that doesn't sound like you. A closer fit may be Alloy (Match Score 65) — or take the quiz to see where Claya lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Claya against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Clayathis provider | CoreAge Rxour #1 | Alloyclosest scorer |
|---|---|---|---|
| Sema price | $299/mo (compounded) | $149/mo | $169/mo (compounded) |
| Coverage | Coverage not published | All 50 states | Coverage not published |
| Formulary | Injectable + oral | Injectable | Injectable + oral + brand |
| Match Score | 65 · C | 91 · A− | 65 · C |
Claya, answered
Is Claya legit?
Claya is a real, operating GLP-1 telehealth program, but we don't find it on the LegitScript registry, so it carries less third-party verification than the certified providers on our board. It dispenses compounded medication, which isn't FDA-approved. Vet the prescriber and pharmacy before you commit.
How much does Claya cost?
Claya lists compounded semaglutide from $299/mo (compounded) and tirzepatide from $299/mo (compounded) — above our category median of $179/mo. These are the provider's public figures at our last review (June 2026); confirm on their site, since some teaser tiers step up after month one.
Does Claya ship to my state?
Claya operates in a limited set of states (Coverage not published). If yours isn't on that list, you'll need a nationwide provider instead.
Claya vs CoreAge Rx — which is better?
Both are on our board. Claya scores 65/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. Claya can still win for you if its strengths match your priorities — best for: People who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. Run the quiz to see which comes out ahead for you.
Pricing & state data last verified June 2026 from Claya's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Claya's site. Not medical advice; see our disclosure.
Claya earns a Match Score of 65/100 (grade C) and sits #194 of 497 on our board under the balanced default weighting. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors. Best for: People who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. If it isn't the right fit, Alloy is a sensible alternative to weigh next.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Claya on the board.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match88/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry on this board.88/100
- #3Match86/ 100HealthRXA LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.86/100
- #4Match86/ 100ShedRxA weight-focused program that also offers an oral/sublingual route for the needle-averse.86/100
- #5Match88/ 100Ondra HealthNear rock-bottom pricing on both molecules plus some brand access — a rare budget-and-breadth combo, nationwide.88/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Contour Health#195 | 65 | $160/mo (starting dose, compounded) | $300/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Fifty 410#196 | 65 | $99/mo (all doses, compounded) | $133/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Injectco#197 | 65 | $156/mo (compounded) | $425/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| LevelsRx#198 | 65 | $150/mo (starting dose, compounded) | $240/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Livv#199 | 65 | $135/mo (starting dose, compounded) | $249/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Loop Health#200 | 65 | $79/mo (plus a separate fee, compounded) | $125/mo (annual plan, plus a separate fee, compounded) | Coverage not published | Alternatives | Visit |
| NexLife#201 | 65 | $165/mo (compounded) | $215/mo (compounded) | Coverage not published | Alternatives | Visit |
| NovoCare Pharmacy#202 | 65 | $349/mo (2.4 mg dose, brand-name) | Not disclosed | All 50 states | Alternatives | Visit |
| Options Medical Weight Loss#203 | 65 | $199/mo (compounded) | $399/mo (compounded) | Coverage not published | Alternatives | Visit |
| ReadyRx#204 | 65 | $179/mo (starting dose, compounded) | $255/mo (starting dose, compounded) | All 50 states | Alternatives | Visit |
| Remote Pharmacy#205 | 65 | $167/mo (all doses, compounded) | $230/mo (all doses, compounded) | Coverage not published | Alternatives | Visit |
| TeleCareSpot#206 | 65 | $299/mo (all doses, plus a separate fee, compounded) | $399/mo | 48 states | Alternatives | Visit |
| TeleHealth Med#207 | 65 | $147/mo (starting dose, compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| YourHealthRx#208 | 65 | $170/mo (compounded) | $210/mo (compounded) | All 50 states | Alternatives | Visit |
| YOURx Health#209 | 65 | $179/mo (compounded) | $199/mo (compounded) | Coverage not published | Alternatives | Visit |
| AVARA Rx#210 | 64 | $229/mo (starting dose, compounded) | $279/mo (starting dose, compounded) | All 50 states | Alternatives | Visit |
| Calibrate Health#211 | 64 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Cielo#212 | 64 | $149/mo (all doses, compounded) | $249/mo (all doses, compounded) | Coverage not published | Alternatives | Visit |
| Clinic Secret#213 | 64 | $196/mo (starting dose, compounded) | $196/mo (compounded) | Coverage not published | Alternatives | Visit |
| Cost Plus Drugs#214 | 64 | $279/mo (brand Ozempic) | Not disclosed | All 50 states | Alternatives | Visit |
| Curve#215 | 64 | $175/mo (compounded) | $225/mo (compounded) | All 50 states | Alternatives | Visit |
| ElixaMD#216 | 64 | $179/mo (starting dose, first-month rate, compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| Eloria#217 | 64 | $179/mo (starting dose, plus a separate fee, compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| Fierce Health#218 | 64 | $297/mo (3-month plan, compounded) | $497/mo (3-month plan, compounded) | 30 states | Alternatives | Visit |